Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form

被引:72
作者
Jansen, K
Schäfer, O
Birkmann, E
Post, K
Serban, H
Prusiner, SB
Riesner, D [1 ]
机构
[1] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Biol Med Forschungszentrum, D-40225 Dusseldorf, Germany
[3] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA
关键词
chemical crosslinks; conformational transition; folding intermediate; oligomerization; size exclusion chromatography; soluble beta-sheet structure;
D O I
10.1515/BC.2001.081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The conversion of the alpha -helical, protease sensitive and noninfectious form of the prion protein (PrPC) into an insoluble, protease resistant, predominantly beta -sheeted and infectious form (PrPSc) is the fundamental event in prion formation. In the present work, two soluble and stable intermediate structural states are newly identified for recombinant Syrian hamster PrP(90-231) (recPrP), a dimeric alpha -helical state and a tetra- or oligomeric, beta -sheet rich state. In 0.2% SDS at room temperature, recPrP is soluble and exhibits alpha -helical and random coil secondary structure as determined by circular dichroism. Reduction of the SDS concentration to 0.06% leads first to a small increase in alpha -helical content, whereas further dilution to 0.02% results in the aquisition of beta -sheet structure. The reversible transition curve is sigmoidal within a narrow range of SDS concentrations (0.04 to 0.02%). Size exclusion chromatography and chemical crosslinking revealed that the alpha -helical form is dimeric, while the beta -sheet rich form is tetra- or oligomeric. Both the alpha -helical and beta -sheet rich intermediates are soluble and stable. Thus, they should be accessible to further structural and mechanistic studies. At 0.01% SDS, the oligomeric intermediates aggregated into large, insoluble structures as observed by fluorescence correlation spectroscopy. Our results are discussed with respect to the mechanism of PrPSc formation and the propagation of prions.
引用
收藏
页码:683 / 691
页数:9
相关论文
共 39 条
[1]   Prion rods contain an inert polysaccharide scaffold [J].
Appel, TR ;
Dumpitak, C ;
Matthiesen, U ;
Riesner, D .
BIOLOGICAL CHEMISTRY, 1999, 380 (11) :1295-1306
[2]   Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible [J].
Donne, DG ;
Viles, JH ;
Groth, D ;
Mehlhorn, I ;
James, TL ;
Cohen, FE ;
Prusiner, SB ;
Wright, PE ;
Dyson, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13452-13457
[3]   SORTING SINGLE MOLECULES - APPLICATION TO DIAGNOSTICS AND EVOLUTIONARY BIOTECHNOLOGY [J].
EIGEN, M ;
RIGLER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :5740-5747
[4]   PERTURBATION OF THE SECONDARY STRUCTURE OF THE SCRAPIE PRION PROTEIN UNDER CONDITIONS THAT ALTER INFECTIVITY [J].
GASSET, M ;
BALDWIN, MA ;
FLETTERICK, RJ ;
PRUSINER, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :1-5
[5]   The importance of the disulfide bond in prion protein conversion [J].
Herrmann, LM ;
Caughey, B .
NEUROREPORT, 1998, 9 (11) :2457-2461
[6]   Protease-resistant prion protein produced in vitro lacks detectable infectivity [J].
Hill, AF ;
Antoniou, M ;
Collinge, J .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :11-14
[7]  
HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305
[8]   Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations [J].
Jackson, GS ;
Hosszu, LLP ;
Power, A ;
Hill, AF ;
Kenney, J ;
Saibil, H ;
Craven, CJ ;
Waltho, JP ;
Clarke, AR ;
Collinge, J .
SCIENCE, 1999, 283 (5409) :1935-1937
[9]   Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform [J].
James, TL ;
Liu, H ;
Ulyanov, NB ;
FarrJones, S ;
Zhang, H ;
Donne, DG ;
Kaneko, K ;
Groth, D ;
Mehlhorn, I ;
Prusiner, SB ;
Cohen, FE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10086-10091
[10]  
Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO